Cardiovascular · PANCE / PANRE

Mitral Stenosis (MS)

Obstruction to LV inflow at the mitral valve — almost always rheumatic; opening snap with diastolic rumble.

Also known as: MS, mitral stenosis, rheumatic mitral disease

Overview

Narrowing of the mitral valve orifice that obstructs diastolic flow from left atrium to left ventricle. Worldwide, almost exclusively rheumatic; degenerative calcific MS is increasingly recognized in older Western patients.

Epidemiology

Most common cause of valvular disease in regions with endemic rheumatic fever. Female predominance ~3:1. Symptoms typically develop 10-30 years after the inciting streptococcal infection.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Mitral Stenosis (MS) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Prior rheumatic fever after untreated group A strep pharyngitis
  • Living in or migrating from areas with endemic rheumatic disease
  • Mitral annular calcification (degenerative MS in elderly)
  • Radiation therapy to the chest
  • Carcinoid heart disease, SLE (Libman-Sacks), congenital MS

Pathophysiology

Rheumatic inflammation causes commissural fusion, leaflet thickening, and chordal shortening — producing a fish-mouth or funnel-shaped orifice. Obstruction raises left atrial pressure, leading to LA enlargement, pulmonary venous congestion, and eventually pulmonary arterial hypertension and right heart failure. The LV itself is typically protected.

Clinical presentation

Symptoms

  • Progressive exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea
  • Fatigue from low cardiac output
  • Hemoptysis (pulmonary venous hypertension, ruptured bronchial veins)
  • Palpitations (atrial fibrillation), embolic stroke
  • Hoarseness (Ortner syndrome — recurrent laryngeal nerve compression by enlarged LA)

Signs / physical exam

  • Loud S1, opening snap shortly after S2
  • Low-pitched mid-diastolic rumble with presystolic accentuation, best heard at apex in left lateral decubitus with bell
  • Shorter A2-OS interval indicates more severe stenosis
  • Right heart failure signs: elevated JVP, peripheral edema, hepatomegaly
  • Mitral facies — pinkish-purple cheek discoloration in advanced disease
  • Loud P2 with pulmonary hypertension

Differential diagnosis

  • Left atrial myxoma — Positional dyspnea, tumor plop instead of opening snap, embolic events; echo shows mobile LA mass
  • Cor triatriatum — Congenital fibromuscular membrane dividing LA; presents in childhood with MS-like physiology
  • Severe mitral annular calcification — Degenerative cause in elderly; echo shows annular Ca²⁺ without commissural fusion
  • Mitral regurgitation — Holosystolic, not diastolic; volume-overload LV instead of pressure-loaded LA only
  • Pulmonary hypertension of other cause — Right-sided signs without diastolic rumble or opening snap
  • Austin Flint murmur of AR — Diastolic rumble at apex but with decrescendo diastolic AR murmur and wide pulse pressure; no opening snap

Diagnostic workup

Diagnostic criteria

Severe MS: mitral valve area ≤1.5 cm² (very severe ≤1.0), mean transmitral gradient >5-10 mmHg at heart rate 60-80, pulmonary artery systolic pressure >50 mmHg with exercise.

Labs

  • CBC, BMP, TSH (Afib workup)
  • BNP, troponin if dyspnea acute
  • Anti-streptolysin O if history unclear

Imaging

  • Transthoracic echo — diagnostic; planimetry of mitral valve area, mean gradient, pulmonary artery pressure, Wilkins score for valvuloplasty candidacy
  • Transesophageal echo to exclude LA appendage thrombus before percutaneous mitral balloon valvuloplasty (PMBV) or cardioversion
  • ECG: P mitrale (broad notched P in lead II), atrial fibrillation, right axis deviation, RVH
  • CXR: straightened left heart border (LA enlargement), Kerley B lines, double density at right heart border, elevated left mainstem bronchus

Diagnostic algorithm

flowchart TD
  A[Symptomatic MS<br/>MVA ≤1.5 cm²] --> B[Transesophageal echo<br/>Wilkins score, LA thrombus?]
  B --> C{Favorable anatomy<br/>Wilkins ≤8?<br/>No thrombus, no MR?}
  C -->|Yes| D[Percutaneous mitral<br/>balloon valvuloplasty]
  C -->|No| E[Surgical mitral<br/>valve replacement]
  D --> F[Lifelong rheumatic<br/>prophylaxis if indicated]
  E --> F
  A --> G[Concurrent: diuretic,<br/>rate control,<br/>WARFARIN if Afib]
Decision pathway for severe symptomatic mitral stenosis.

Treatment

First-line

  • Diuretics (furosemide, torsemide) for pulmonary and systemic congestion
  • Rate control for Afib: beta-blocker (metoprolol, bisoprolol) or non-dihydropyridine CCB (diltiazem, verapamil) to lengthen diastolic filling time
  • Anticoagulation with WARFARIN (target INR 2-3) for Afib, prior embolism, or LA thrombus — DOACs are CONTRAINDICATED in rheumatic MS
  • Secondary rheumatic fever prophylaxis with IM benzathine penicillin G every 3-4 weeks for at-risk patients

Second-line / adjunct

  • Percutaneous mitral balloon valvuloplasty (PMBV) — preferred when symptomatic severe MS with favorable valve morphology (low Wilkins score ≤8, no significant MR, no LA thrombus)
  • Surgical mitral valve repair or replacement (mechanical or bioprosthetic) — for unfavorable anatomy, concomitant valve disease, or failed PMBV
  • Bioprosthetic valve preferred in older patients; mechanical in younger patients willing to take lifelong warfarin

Complications

  • Atrial fibrillation and systemic embolism (especially stroke)
  • Pulmonary hypertension and right heart failure
  • Infective endocarditis
  • Hemoptysis
  • Recurrent rheumatic activity

PANCE pearls

  • DOACs (apixaban, rivaroxaban, dabigatran) are NOT used in rheumatic MS — use warfarin only.
  • Pregnancy unmasks MS: increased blood volume and HR shorten diastole, raising LA pressure dramatically.
  • A shorter A2-OS interval suggests more severe stenosis (higher LA pressure opens the valve sooner).
  • Ortner syndrome — hoarseness from giant LA compressing the recurrent laryngeal nerve.
  • PMBV requires absence of LA thrombus on TEE and low Wilkins score; otherwise pursue surgery.

References

  • ACC/AHA 2020 VHD — 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease (Otto et al., Circulation 2021)
  • ESC/EACTS 2021 — 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease (Vahanian et al., Eur Heart J 2022)
  • INVICTUS Trial — Rivaroxaban vs Vitamin K Antagonist in Rheumatic Atrial Fibrillation (Connolly et al., NEJM 2022)

Practice Cardiovascular questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.